--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "MDLIVE: Talk to a Doctor 24/7" developer_entity: "MDLIVE Inc" bundle_id: "com.mdlive.mobile" category: "Medical" primary_platform: "android" primary_monetization: "Freemium" offline_capable: false market_region: "US" platforms: "Android" app_last_updated: "2026-07-02" report_date: "2026-08-07" last_verified: "2026-08-07T00:00:00.000Z" report_version: "6.9.0.0" total_reviews: 17901 overall_rating: 4.6 sentiment: "Mixed" sentiment_score: 45 confidence: "high" confidence_score: 0.75 top_praise_theme: "Virtual consultations provide rapid access to medical professionals without the need for travel or long wait times" top_complaint_theme: "Technical failures during the appointment scheduling process prevent users from confirming visits despite completing all required intake fields" review_sample_size: 50 total_review_count: 50 analyzed_review_count: 50 data_age_days: 9 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "freemium", "mixed sentiment", "mobile app", "app review", "app analysis", "individuals", "seeking", "non-emergency"] canonical_url: "https://marlvel.ai/apps/mdlive-talk-to-a-doctor-24-7" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # MDLIVE: Talk to a Doctor 24/7 Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Freemium - **Signal**: Rating 4.59 · Sentiment Mixed - **Recent focus**: Technical failures during the appointment scheduling process prevent users from confirming visits despite completing all required intake fields (top complaint) · Virtual consultations provide rapid access to medical professionals without the need for travel or long wait times (top praise) > **TL;DR:** MDLIVE: Talk to a Doctor 24/7 is a medical app by MDLIVE Inc, rated 4.59/5 by 17.9K users, with Mixed user sentiment (45/100), available on Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** MDLIVE: Talk to a Doctor 24/7 shows Mixed sentiment (4.59/5 from 17.9K reviews) - users praise virtual consultations provide rapid access to medical professionals without the need for travel or long wait times but report issues with technical failures during the appointment scheduling process prevent users from confirming visits despite completing all required intake fields. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.59/5 (17.9K reviews) | | **User Mood** | Mixed | | **Category** | Medical | | **Developer** | MDLIVE Inc | | **Pricing** | Freemium | | **Platforms** | Android | | **Confidence** | High (0.75/1.0) | | **Data Age** | 9d | ## Metadata & Market Performance - **Publisher:** MDLIVE Inc - **Category:** Medical - **Target Audience:** Individuals seeking non-emergency medical, mental health, or dermatological care with access to employer or health plan benefits. - **Platforms:** Android - **Version Reviewed:** 6.9.0.0 - **Report Date:** 2026-08-07 - **Signal Count:** 50 reviews analyzed - **Confidence:** High (0.75/1.0) - **Google Play ID:** com.mdlive.mobile - **Performance Trend:** Stable - **Data Window:** Analysis based on signals collected up to 2026-08-07 - **Short Description:** The MDLIVE app makes connecting with a doctor fast, easy, and convenient. ## Executive Snapshot **What it is:** MDLIVE is a telehealth platform providing 24/7 virtual medical, behavioral health, and dermatology consultations for patients on iOS and Android. **Why users hire it:** Users hire the service for convenient, on-demand access to board-certified physicians when traditional office visits are unavailable or inaccessible. ## App DNA (Features & Intent) - **[Standard] 24/7 Virtual Consultations:** On-demand access to board-certified physicians via phone or video. - **[Differentiator] Insurance Integration:** Verification of coverage for major health plans to determine copay amounts. ## Market Position {#market-position} MDLIVE holds the #64 Free position in the US Medical category. The reliance on insurance verification creates a significant friction point compared to direct-pay competitors. ## Monetization Strategy - **Model:** Freemium - **Tiers:** Urgent Care: $0-$89, Primary Care: $0 (via insurance), Therapy: $0-$179, Psychiatry: $0-$299 - **Analysis:** Service-based pricing anchored by insurance coverage, with costs displayed upfront to prevent surprise billing. ## 🟡 User Sentiment (High Confidence: 50 of 50 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.59/5 - **Platform Split:** Android 4.6/5 (17.9K ratings) - **Overall Sentiment:** Mixed ### Top Praises - **Virtual consultations provide rapid access to medical professionals without the need for travel or long wait times** - **Mental health providers available through the platform are described as highly effective and supportive by long-term users** ### Top Complaints (Impact Areas) - **Technical failures during the appointment scheduling process prevent users from confirming visits despite completing all required intake fields** ## SWOT Analysis {#swot} **Core Strengths:** - National Committee for Quality Assurance certifications establish clinical credibility - Board-certified physician network provides 24/7 coverage **Growth Levers:** - Direct messaging feature could reduce customer service volume ## Recent Changes (v2 → v3) {#recent-changes} The platform remains in maintenance mode with no feature or pricing changes, though the competitive narrative has shifted to acknowledge the friction caused by insurance-based billing. **Overall trend**: Stable **Compared at**: 2026-08-07 ### Medium-impact changes - **[Added] Clinical Credibility Anchor** (swot) - **[Shifted] Insurance Model Framing** (positioning) - **[Added] Threat Identification** (swot) ## What's New - **Latest (v6.9.0.0, 1 months ago):** General performance, speed, and reliability improvements. ## App Momentum (Maintenance) {#momentum} - Ships bug fixes at 5-week cadence. - No new feature builds released recently. > **Cadence:** 1 total versions · 0 majors in last 6 months · 35 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} MDLIVE: Talk to a Doctor 24/7 is a medical app that is free with in-app purchases. With a 4.59/5 rating from 17.9K reviews, it shows mixed user reception. > **Bottom Line:** MDLIVE delivers clinical access via insurance integration, but technical scheduling failures and billing disputes erode the user experience, so the team must prioritize stabilizing the intake flow to prevent churn to more reliable telehealth alternatives. **Best for:** Individuals seeking non-emergency medical, mental health, or dermatological care with access to employer or health plan benefits. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Rebuild scheduling intake flow because scheduling freezes are a top complaint → reduce drop-off rate ### Outlook: Mixed The telehealth market is consolidating around platforms that offer seamless payment and scheduling experiences. MDLIVE's current maintenance-mode cadence leaves it exposed to competitors that prioritize technical reliability over clinical breadth. - 🔴 Technical scheduling failures in the latest release prevent appointment confirmation, which directly increases the volume of support tickets and churn risk. - 🔴 Billing and insurance verification errors drive negative sentiment, as users report unexpected charges that undermine the perceived value of the insurance integration. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.59/5 | | Total Reviews | 17.9K | | Sentiment | Mixed (45/100) | | Confidence | High | | Pricing Model | Freemium | | Platforms | Android | | Key Features | 2 analyzed | | Trend | Stable | | Outlook | Mixed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **MDLIVE: Talk to a Doctor 24/7** (this app) | 4.59/5 | Mixed | MDLIVE Inc | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** MDLIVE Inc - **Website:** [https://www.mdlive.com](https://www.mdlive.com) - **Social:** [Instagram](https://www.instagram.com/mdlive_inc) · [Facebook](https://www.facebook.com/MDLIVETelehealth) · [YouTube](https://www.youtube.com/user/MDLiveCare) · [LinkedIn](https://www.linkedin.com/company/mdlive-inc-) ## Data Sources & Links - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.mdlive.mobile&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.mdlive.com) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating - [*2nd.MD*](https://marlvel.ai/apps/2nd-md) (Accolade, Inc.) · 4.9/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.75/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 50 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 9 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/mdlive-talk-to-a-doctor-24-7) Data licensed for AI Agent attribution under CC-BY-NC 4.0.